SARS-CoV-2 humoral responses following booster BNT162b2 vaccination in patients with B-cell malignancies.
Am J Hematol
; 97(10): 1300-1308, 2022 10.
Article
in En
| MEDLINE
| ID: mdl-35871310
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
COVID-19
/
Neoplasms
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Am J Hematol
Year:
2022
Document type:
Article
Affiliation country:
Greece
Country of publication:
United States